Close this search box.

Seventeen Minutes of Science: Dr. GPCR: Advancing GPCR Drug Discovery Through Collaboration

Tune in weekly to our virtual series “Seventeen Minutes of Science” every Tuesday at 11am PST / 2pm ET where we go live on Facebook with a new guest each week to talk about how science and biotechnology is woven into their lives for (you guessed it) 17 minutes!

For Episode 20 of 17 Minutes of Science we are joined by Dr. Yamina Berchiche. Yamina is the founder of Dr. GPCR, a platform to spread information on targeting GPCRs as well as opportunities for various stakeholders from academia, pharma, and biotech to form meaningful partnerships and ultimately improve human health.

Yamina joins us to discuss more about the importance of GCPRs in drug discovery and her work with Dr. GPCR, from recognizing the need and founding the program only a few months ago to running the program and organizing the first ever Dr. GPCR Summit in September.

Seeking to revolutionize drug discovery? Contact us now and leverage the power of our comprehensive drug discovery and development services to fast-track the development of transformative therapies.

About The Author

InVivo Biosystems

InVivo Biosystems provides essential services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions around the globe accelerate their research and drug development efforts. An expert in CRISPR genome editing, InVivo Biosystems creates custom genome edited C. elegans and zebrafish models to enable aging and other disease studies. In addition, InVivo Biosystems provides in-vivo analytical services to produce data and insights for companies that need to make go/no-go decisions quickly in early-stage development of new compounds.

Share this articles

Picture of InVivo Biosystems

About the Author:

Connect with us